{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:39:40Z","timestamp":1787024380168,"version":"build-2736575974"},"reference-count":30,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MDER"],"DOI":"10.2147\/mder.s412802","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:10:05Z","timestamp":1684444205000},"page":"111-122","source":"Crossref","is-referenced-by-count":9,"title":["Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9347-494X","authenticated-orcid":true,"given":"Maryam","family":"Mooghali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-3320","authenticated-orcid":true,"given":"Joseph S","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushal T","family":"Kadakia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket S","family":"Dhruva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,5]]},"reference":[{"key":"ref1","unstructured":"U.S. Food and Drug Administration. Regulatory controls. Available from: https:\/\/www.fda.gov\/medical-devices\/overview-device-regulation\/regulatory-controls. Accessed March 15, 2023."},{"key":"ref2","unstructured":"U.S. Food and Drug Administration. Premarket notification 510(k). Available from: https:\/\/www.fda.gov\/medical-devices\/premarket-submissions-selecting-and-preparing-correct-submission\/premarket-notification-510k. Accessed March 15, 2023."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1001\/jama.2015.8761","volume":"314","author":"Rathi","year":"2015","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1001\/jama.2009.1899","volume":"302","author":"Dhruva","year":"2009","journal-title":"JAMA"},{"key":"ref5","unstructured":"U.S. Food and Drug Administration. MDR data files. Available from: https:\/\/www.fda.gov\/medical-devices\/medical-device-reporting-mdr-how-report-medical-device-problems\/mdr-data-files. Accessed March 15, 2023."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/jamainternmed.2020.3514","volume":"180","author":"Tau","year":"2020","journal-title":"JAMA Intern Med"},{"key":"ref7","unstructured":"U.S. Food and Drug Administration. Recalls, corrections and removals (devices). Available from: https:\/\/www.fda.gov\/medical-devices\/postmarket-requirements-devices\/recalls-corrections-and-removals-devices. Accessed March 15, 2023."},{"key":"ref8","unstructured":"U.S. Food and Drug Administration. Recalls background and definitions. Available from: https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions. Accessed March 15, 2023."},{"key":"ref9","unstructured":"U.S. Food and Drug Administration. Recalls. Available from: https:\/\/datadashboard.fda.gov\/ora\/cd\/recalls.htm. Accessed March 15, 2023."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e217274","DOI":"10.1001\/jamanetworkopen.2021.7274","volume":"4","author":"Dubin","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.arth.2020.03.025","volume":"35","author":"Vajapey","year":"2020","journal-title":"J Arthroplasty"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/03091902.2019.1580778","volume":"42","author":"Sarkissian","year":"2018","journal-title":"J Med Eng Technol"},{"key":"ref13","unstructured":"U.S. Food and Drug Administration. Initiation of voluntary recalls under 21 CFR part 7, subpart C. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/initiation-voluntary-recalls-under-21-cfr-part-7-subpart-c. Accessed April 25, 2023."},{"key":"ref14","unstructured":"Taylor NP. FDA class I recalls hit 15-year high in 2022. MedTech Dive. Available from: https:\/\/www.medtechdive.com\/news\/fda-class-i-recall-2022-ABT-BAX-GEHC-MDT-PHG\/644072\/. Accessed March 15, 2023."},{"key":"ref15","unstructured":"U.S. Food and Drug Administration. Medical device recalls. Available from: https:\/\/www.fda.gov\/medical-devices\/medical-device-safety\/medical-device-recalls. Accessed March 15, 2023."},{"key":"ref16","unstructured":"U.S. Food and Drug Administration. Medical device recalls. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfRES\/res.cfm. Accessed March 15, 2023."},{"key":"ref17","unstructured":"U.S. Government Accountability Office (GAO). Medical devices: FDA should enhance its oversight of recalls. Available from: https:\/\/www.gao.gov\/assets\/a319569.html. Accessed March 15, 2023."},{"key":"ref18","unstructured":"U.S. Food and Drug Administration. Breakthrough devices program. Available from: https:\/\/www.fda.gov\/medical-devices\/how-study-and-market-your-device\/breakthrough-devices-program. Accessed March 15, 2023."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamainternmed.2022.5141","volume":"183","author":"Kadakia","year":"2023","journal-title":"JAMA Intern Med"},{"key":"ref20","unstructured":"Association for Healthcare Resource & Materials Management. Unique Device Identifier (UDI) impacts on recall management executive summary. Available from: https:\/\/www.ahrmm.org\/system\/files\/media\/file\/2021\/09\/UDI-DI-Recall-Impact-Executive-Summary.pdf. Accessed March 15, 2023."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamainternmed.2020.7797","volume":"181","author":"Kinard","year":"2021","journal-title":"JAMA Intern Med"},{"key":"ref22","unstructured":"U.S. Food and Drug Administration. Unique Device Identification System (UDI System). Available from: https:\/\/www.fda.gov\/medical-devices\/device-advice-comprehensive-regulatory-assistance\/unique-device-identification-system-udi-system. Accessed March 15, 2023."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.0727","author":"Mooghali","year":"2023","journal-title":"JAMA Intern Med"},{"key":"ref24","unstructured":"U.S. Food and Drug Administration. MAUDE - Manufacturer and User Facility Device Experience. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/search.cfm. Accessed March 15, 2023."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1001\/jamainternmed.2020.3512","volume":"180","author":"Tomes","year":"2020","journal-title":"JAMA Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bmj.p82","volume":"380","author":"Kadakia","year":"2023","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jama.2019.10191","volume":"322","author":"Redberg","year":"2019","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamainternmed.2021.6626","volume":"182","author":"Kadakia","year":"2022","journal-title":"JAMA Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.5141","author":"Kadakia","year":"2022","journal-title":"JAMA Intern Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archinternmed.2011.30","volume":"171","author":"Zuckerman","year":"2011","journal-title":"Arch Intern Med"}],"container-title":["Medical Devices: Evidence and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89827","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89827","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:10:11Z","timestamp":1684444211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/characterization-of-us-food-and-drug-administration-class-i-recalls-fr-peer-reviewed-fulltext-article-MDER"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2147\/mder.s412802","relation":{},"ISSN":["1179-1470"],"issn-type":[{"value":"1179-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}